Catalyst
Slingshot members are tracking this event:
Aimmune (AIMT) Completes Enrollment for Phase 3 PALISADE Trial Evaluating AR101 in Peanut Allergies
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| AIMT |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 28, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Enrollment, Phase 3, Palisade, Ar101, Peanut Allergies
